-
The Future Of Nano Technology
Categories
- Ai
- Alan Watts
- Anatomy
- Andropause
- Anti-Aging Medicine
- Arthritis
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ataxia
- Autism
- Biochemistry
- BioEngineering
- Biotechnology
- Bitcoin
- Chemistry
- Cryonics
- Cryptocurrency
- David Sinclair
- Dementia
- Diet Science
- Diseases
- Eczema
- Elon Musk
- Futurism
- Gene Medicine
- Gene Therapy
- Gene therapy
- Genetic Medicine
- Genetic Therapy
- Global News Feed
- Healthy Lifestyle
- Healthy Living
- HGH Physicians
- Hormone Optimization
- Hormone Replacement Therapy
- Hormone Replacement Treatment
- Human Genetic Engineering
- Human Immortality
- Human Longevity
- Human Reproduction
- Hypogonadism
- Hypopituitarism
- Hypothyroidism
- Immortality
- Immortality Medicine
- Inflammation
- Injectable Growth Hormone
- Integrative Medicine
- Life Skills
- Longevity
- Longevity Medicine
- Low T
- Machine Learning
- Mars Colony
- Medical School
- Menopause
- multiple-sclerosis
- Nano Medicine
- Nanomedicine
- Nanotechnology
- Neurology
- Parkinson's disease
- Pharmacogenomics
- Protein Folding
- Psoriasis
- Quantum Computing
- Regenerative Medicine
- Resveratrol
- Sermorelin Physicians
- Singularity
- Spacex
- Stem Cell Therapy
- Stem Cells
- Stemcell Therapy
- Testosterone
- Testosterone Physicians
- Transhuman
- Transhumanism
- Transhumanist
- Uncategorized
- Veganism
- Vegetarianism
- Vitamin Research
- Wellness
-
Recent Posts
- Cheap longevity drug? Researchers aim to test if metformin can slow down aging : Shots – Health News – NPR
- The U.S. Needs to ‘Get It Right’ on AI – TIME
- Big Tech keeps spending billions on AI. There’s no end in sight. – The Washington Post
- Racist AI Deepfake of Baltimore Principal Leads to Arrest – The New York Times
- A Baltimore-area teacher is accused of using AI to make his boss appear racist – NPR
Archives
Popular Key Word Searches
- centraltph
- bicarbonate and growth immunity ray peat
- vrcc neurology
- bibliotecapleyades/amrita-longevity-immortality
- cbr xmen anatomy
- Medical genetics wikipedia
- immortality medicine
- GrabPay
- Grab Pay Philippines
- GrabPay Vietnam
- GrabPay Philippines
- dr weil psoriasis
- what does recovered mean covid-19
- tony pantalleresco
- tony pantalleresco herbalist book
- herbsplusbeadworks
- herbsplusbeadworks website
- hailie vanderven
- princeton longevity center scam
- aetna genetic testing policy
- anatomy of hell
- biggie
- longevity claims
- augmentinforce tony pantalleresco
- tony pantalleresco website
| Search Immortality Topics: |
Category Archives: Stem Cell Therapy
Two California Stem Cell Agency Directors Plump for Proposition 29
Two directors of the $3 billion
California stem cell agency have popped up in the battle over the
anti-tobacco initiative on tomorrow's ballot in the Golden State.
They are Sherry Lansing and
Kristiina Vuori, who were the subjects of a column by Michael
Hiltzik of the Los Angeles Times dealing with Proposition
29, the "Son of CIRM" measure that would raise
$800 million for research by increasing the price of cigarettes by $1
a pack. In addition to serving on the CIRM board, Lansing heads her
own anti-cancer foundation and is chair of the board of the UC
regents. Vuori is head of the Sanford-Burnham Institute in La
Jolla.
Kristiina Vuori, who were the subjects of a column by Michael
Hiltzik of the Los Angeles Times dealing with Proposition
29, the "Son of CIRM" measure that would raise
$800 million for research by increasing the price of cigarettes by $1
a pack. In addition to serving on the CIRM board, Lansing heads her
own anti-cancer foundation and is chair of the board of the UC
regents. Vuori is head of the Sanford-Burnham Institute in La
Jolla.
Proposition 29 is patterned after the
measure that created the stem cell agency. The organization established by Proposition 29 would also be governed by a board that is run by
representatives of organizations almost certain to receive the bulk
of the funding, as is the case with CIRM.
measure that created the stem cell agency. The organization established by Proposition 29 would also be governed by a board that is run by
representatives of organizations almost certain to receive the bulk
of the funding, as is the case with CIRM.
In an op-ed piece on Friday, Lansing and
Vuori said the Times and Hiltzik had fallen for "a smokescreen"
put up by tobacco companies which are spending something in the
neighborhood of $40 million to defeat the initiative. Lansing and
Vuori said the measure is needed to stop smoking by young people as
well as providing cash for research for tobacco-related diseases.
Young people are more sensitive to price increases of cigarettes than
adults, according to research.
Vuori said the Times and Hiltzik had fallen for "a smokescreen"
put up by tobacco companies which are spending something in the
neighborhood of $40 million to defeat the initiative. Lansing and
Vuori said the measure is needed to stop smoking by young people as
well as providing cash for research for tobacco-related diseases.
Young people are more sensitive to price increases of cigarettes than
adults, according to research.
Lansing and Vuori referred to a column
in which Hiltzik opposed the measure because it would divert money
from more immediate state needs, including health and welfare
programs for children, education and the poor. (See here for thecolumn and here, here and here for related items.)
in which Hiltzik opposed the measure because it would divert money
from more immediate state needs, including health and welfare
programs for children, education and the poor. (See here for thecolumn and here, here and here for related items.)
In his most recent column, Hiltzik
said,
said,
"The...problem with Proposition 29
is its pigeonholing of the money for cancer research rather than for
immediate needs here in California that are absolutely dire. It’s
all well and good to say that cancer research benefits everyone, but
the real question is whether it should be the absolute top priority
for a state that can’t afford to keep its children fed or offer
them medical care in the here and now.
"Lansing and Vuori say the fact
that Prop. 29 'fails to provide funding for schools, roads or
affordable housing' is irrelevant, because it was 'was never intended
to solve these problems.'"In the context of the state’s
needs, this is a rather callous approach to take. Let’s spell out
why, so Lansing and Vuori won’t be so inclined to dismiss these
necessities of life so casually."
Hiltzik cited a list of state
government cuts that have meant the loss of health coverage for
400,000 California children, eliminated welfare benefits for 578,000
poor California families and would mean an end to state college
student aid for 72,000 young people from less affluent families.
government cuts that have meant the loss of health coverage for
400,000 California children, eliminated welfare benefits for 578,000
poor California families and would mean an end to state college
student aid for 72,000 young people from less affluent families.
Hiltzik continued,
"That’s just the beginning of
what might be cut because the state needs money—and won’t be able
to lay its hands on the hundreds of millions of dollars that Lansing,
Vuori, and their research colleagues are angling for. They don’t
want voters to be reminded that there are competing demands for the
tobacco money, and they do so by failing to mention that they exist,
and also by presenting the spending on cancer research as the voters’
only choice.
"It’s the only choice because
the promoters of Proposition 29 designed it that way. Advocates of
programs like this love to pass them in via voter initiatives because
they leave no room to measure them against alternative needs."
A final note: The New York Times
carried a piece yesterday on Proposition 29 that drew 481 comments.
The article said,
carried a piece yesterday on Proposition 29 that drew 481 comments.
The article said,
"Organizers argued that the tax would have
less chance of passing if voters thought it would go into the state
coffers, and said that their only goal here was cutting down on
smoking."
Also yesterday, Willie Brown, the former mayor
of San Francisco and a keen observer of California politics,
predicted voter approval of the measure along with an increase in
cigarette smuggling from adjacent states and the sale of discount
smokes at the 58 Indian casino sites in the state.
of San Francisco and a keen observer of California politics,
predicted voter approval of the measure along with an increase in
cigarette smuggling from adjacent states and the sale of discount
smokes at the 58 Indian casino sites in the state.
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss
Posted in Stem Cell Therapy, Stem Cells
Comments Off on Two California Stem Cell Agency Directors Plump for Proposition 29
Business Success Rate at Stem Cell Agency: Zero in Latest Round After 14 Fail
California biotech companies chalked up
a zero in the latest funding round by the state's $3 billion stem
cell agency, although 14 tried to run a gauntlet that industry has
complained about for years.
All $69 million in last month's
translational research round went to 21 academic and nonprofit insitutions. No business received an award. One firm, Eclipse
Therapeutics of San Diego, appealed to the agency's governing board but was not successful despite having a higher scientific score
than at least two winners.
translational research round went to 21 academic and nonprofit insitutions. No business received an award. One firm, Eclipse
Therapeutics of San Diego, appealed to the agency's governing board but was not successful despite having a higher scientific score
than at least two winners.
The miniscule amount of funding for
commercial enterprises – less than 4 percent of $1.4 billion handed
out so far – has been a matter of concern for some time for both
industry and some members of the CIRM governing board. Most
recently, industry executives complained at an April hearing of the
Institute of Medicine panel looking into CIRM's operations.
Even a 2010 review commissioned by CIRM said the agency needed to do
better by business.
commercial enterprises – less than 4 percent of $1.4 billion handed
out so far – has been a matter of concern for some time for both
industry and some members of the CIRM governing board. Most
recently, industry executives complained at an April hearing of the
Institute of Medicine panel looking into CIRM's operations.
Even a 2010 review commissioned by CIRM said the agency needed to do
better by business.
The question of funding goes beyond a
simple matter of fairness or "good science," as CIRM
describes its funding goal. Without efforts by industry to turn
research into cures, CIRM will not be able to fulfill promises to
voters in 2004 when they approved creation of the stem cell agency.
CIRM last month approved a set of five-year goals that push more
aggressively for development of commercial products, but the goals
lacked such things as a financing round devoted solely to business
applicants.
simple matter of fairness or "good science," as CIRM
describes its funding goal. Without efforts by industry to turn
research into cures, CIRM will not be able to fulfill promises to
voters in 2004 when they approved creation of the stem cell agency.
CIRM last month approved a set of five-year goals that push more
aggressively for development of commercial products, but the goals
lacked such things as a financing round devoted solely to business
applicants.
In last month's translational round,
applicants went through a three-step process, which is conducted
primarily behind closed doors. First came what CIRM calls
pre-applications. Those were reviewed by CIRM staff with the help of
outside advisors if necessary. Applicants who cleared that hurdle were allowed to apply for the full, peer-reviewed round. During that
process, the CIRM Grants Working Group reviews applications,
makes decisions and sends them to the full CIRM board for
ratification and possible changes. The board almost never has
rejected a grant approved by reviewers. But the board has ultimate
authority and sometimes funds applications that reviewers have
rejected. The applicants' names are withheld from the board and the
public during the process, although some of the board discussion and
the final vote is conducted in public. CIRM does not release the
names of rejected applicants unless they appeal.
applicants went through a three-step process, which is conducted
primarily behind closed doors. First came what CIRM calls
pre-applications. Those were reviewed by CIRM staff with the help of
outside advisors if necessary. Applicants who cleared that hurdle were allowed to apply for the full, peer-reviewed round. During that
process, the CIRM Grants Working Group reviews applications,
makes decisions and sends them to the full CIRM board for
ratification and possible changes. The board almost never has
rejected a grant approved by reviewers. But the board has ultimate
authority and sometimes funds applications that reviewers have
rejected. The applicants' names are withheld from the board and the
public during the process, although some of the board discussion and
the final vote is conducted in public. CIRM does not release the
names of rejected applicants unless they appeal.
In the translational round, a total of 42
pre-applications out of 167 were approved by staff, according to
CIRM. Thirty-eight came from nonprofits and academics out of the 153
such institutions that applied. Four out of 14 business
pre-applications advanced to full applications but none made the
final cut. All of the winning applications were linked to
institutions that have representatives on the CIRM governing board.
Those representatives are not allowed to vote on or take part in
discussion involving applications to their institutions.
pre-applications out of 167 were approved by staff, according to
CIRM. Thirty-eight came from nonprofits and academics out of the 153
such institutions that applied. Four out of 14 business
pre-applications advanced to full applications but none made the
final cut. All of the winning applications were linked to
institutions that have representatives on the CIRM governing board.
Those representatives are not allowed to vote on or take part in
discussion involving applications to their institutions.
The primary decision tool used by the
grant review group is a scientific score. In last month's round,
scores of approved grants ranged from 88 to 53. However, eight grants
that were ranked above 53 were rejected by the board. One of those
higher-ranking applications came from San Diego's Eclipse
Therapeutics, which scored 58. The low-ranking grants were approved
for what CIRM describes as "programmatic" reasons.
grant review group is a scientific score. In last month's round,
scores of approved grants ranged from 88 to 53. However, eight grants
that were ranked above 53 were rejected by the board. One of those
higher-ranking applications came from San Diego's Eclipse
Therapeutics, which scored 58. The low-ranking grants were approved
for what CIRM describes as "programmatic" reasons.
More than three weeks ago, the
California Stem Cell Report asked CIRM for figures on the
numbers of applications in the translational round, including those
for business. CIRM said the figures had not been compiled and would
not be available until after the awards were made on May 24. The
numbers were finally supplied yesterday.
California Stem Cell Report asked CIRM for figures on the
numbers of applications in the translational round, including those
for business. CIRM said the figures had not been compiled and would
not be available until after the awards were made on May 24. The
numbers were finally supplied yesterday.
Our take: The number of applicants, and
their breakdown, is basic information that should be part of board's
decision-making process. The statistics should be routinely available
well in advance of the board's meeting. Indeed, the agency in its
earlier days used to routinely publish the figures. It may be now
that generating them is more time-consuming than necessary. The
recent performance evaluation of the agency said CIRM needs to make
major improvements in how it handles critical information needed for
its top management and board.
their breakdown, is basic information that should be part of board's
decision-making process. The statistics should be routinely available
well in advance of the board's meeting. Indeed, the agency in its
earlier days used to routinely publish the figures. It may be now
that generating them is more time-consuming than necessary. The
recent performance evaluation of the agency said CIRM needs to make
major improvements in how it handles critical information needed for
its top management and board.
Whatever the reason, given CIRM's poor
track record with business, the agency's directors should diligently
track industry's success rate on applications. If proposals ranked as
low as 53 are approved while higher ranking applications from
business are bypassed, it warrants more than cursory examination.
track record with business, the agency's directors should diligently
track industry's success rate on applications. If proposals ranked as
low as 53 are approved while higher ranking applications from
business are bypassed, it warrants more than cursory examination.
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss
Posted in Stem Cell Therapy
Comments Off on Business Success Rate at Stem Cell Agency: Zero in Latest Round After 14 Fail
Business-friendly Changes Proposed for Revenue Sharing by Stem Cell Agency
The $3 billion California stem cell
agency, which hopes to generate income for the state through the sale
of stem cell therapies, is moving to make its profit-sharing rules
more friendly to business.
The proposed changes will come up Monday morning before the Intellectual Property and Industry Subcommittee of the
CIRM governing board.
CIRM governing board.
No stem cell research funded by CIRM
has yet been commercialized. Its intellectual property regulations,
which determine payback criteria, were developed shortly after CIRM
was created in 2004. Ed Penhoet, one of the founders of
Chiron and now a venture capitalist, chaired the panel that worked
out the rules. He has since left the CIRM board.
has yet been commercialized. Its intellectual property regulations,
which determine payback criteria, were developed shortly after CIRM
was created in 2004. Ed Penhoet, one of the founders of
Chiron and now a venture capitalist, chaired the panel that worked
out the rules. He has since left the CIRM board.
A CIRM staff memo described the payment
rules in the case of a "blockbuster" therapy as "uneven"
and "lumpy." The memo said they "could be a
disincentive for the engagement of industry." Other rules were described as creating
"administrative challenges and uncertainty." The proposed changes, the memo said,
would address those issues and ensure a "comparable economic
return to California."
rules in the case of a "blockbuster" therapy as "uneven"
and "lumpy." The memo said they "could be a
disincentive for the engagement of industry." Other rules were described as creating
"administrative challenges and uncertainty." The proposed changes, the memo said,
would address those issues and ensure a "comparable economic
return to California."
Public sites where interested parties
can take part in the discussion are located in San Francisco, La
Jolla, Los Angeles and Irvine. Specific addresses can be found on themeeting agenda.
can take part in the discussion are located in San Francisco, La
Jolla, Los Angeles and Irvine. Specific addresses can be found on themeeting agenda.
The proposed changes must go before the
full governing board and then into the state's administrative law
process before taking full effect.
full governing board and then into the state's administrative law
process before taking full effect.
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss
Posted in Stem Cell Therapy
Comments Off on Business-friendly Changes Proposed for Revenue Sharing by Stem Cell Agency
‘Ugly’ Stem Cell Headlines and a Stem Cell Essay Contest
California stem cell researcher Paul Knoepfler has been busy recently pumping out a plethora of items on his blog, including his own stem cell essay contest and a summary of "ugly" stem cell headlines.
He also rails, albeit briefly, against the Los Angeles Times "hate fest" against the California stem cell agency and offers some advice on developments involving prostate cancer, an affliction that he suffered from a few years ago.
Knoepfler, a UC Davis scientist, puts some cash on the line in his essay contest, with a prize of a $50 iTunes card plus publication of the winning piece. He is looking for a "convincing, non-fiction essay on stem cells thinking entirely outside the box." No more than 500 words. He has two categories, one for persons under 18 and one for persons over that age. June 30 is the deadline for submissions.
Knoepfler also wrote about Twitter and how it can be used by scientists in a useful item called "The scientist's top 10 guide to Twitter." We recommend it.
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss
Posted in Stem Cell Therapy
Comments Off on ‘Ugly’ Stem Cell Headlines and a Stem Cell Essay Contest
Two California Stem Cell Agency Directors Plump for Proposition 29
Two directors of the $3 billion
California stem cell agency have popped up in the battle over the
anti-tobacco initiative on tomorrow's ballot in the Golden State.
They are Sherry Lansing and
Kristiina Vuori, who were the subjects of a column by Michael
Hiltzik of the Los Angeles Times dealing with Proposition
29, the "Son of CIRM" measure that would raise
$800 million for research by increasing the price of cigarettes by $1
a pack. In addition to serving on the CIRM board, Lansing heads her
own anti-cancer foundation and is chair of the board of the UC
regents. Vuori is head of the Sanford-Burnham Institute in La
Jolla.
Kristiina Vuori, who were the subjects of a column by Michael
Hiltzik of the Los Angeles Times dealing with Proposition
29, the "Son of CIRM" measure that would raise
$800 million for research by increasing the price of cigarettes by $1
a pack. In addition to serving on the CIRM board, Lansing heads her
own anti-cancer foundation and is chair of the board of the UC
regents. Vuori is head of the Sanford-Burnham Institute in La
Jolla.
Proposition 29 is patterned after the
measure that created the stem cell agency. The organization established by Proposition 29 would also be governed by a board that is run by
representatives of organizations almost certain to receive the bulk
of the funding, as is the case with CIRM.
measure that created the stem cell agency. The organization established by Proposition 29 would also be governed by a board that is run by
representatives of organizations almost certain to receive the bulk
of the funding, as is the case with CIRM.
In an op-ed piece on Friday, Lansing and
Vuori said the Times and Hiltzik had fallen for "a smokescreen"
put up by tobacco companies which are spending something in the
neighborhood of $40 million to defeat the initiative. Lansing and
Vuori said the measure is needed to stop smoking by young people as
well as providing cash for research for tobacco-related diseases.
Young people are more sensitive to price increases of cigarettes than
adults, according to research.
Vuori said the Times and Hiltzik had fallen for "a smokescreen"
put up by tobacco companies which are spending something in the
neighborhood of $40 million to defeat the initiative. Lansing and
Vuori said the measure is needed to stop smoking by young people as
well as providing cash for research for tobacco-related diseases.
Young people are more sensitive to price increases of cigarettes than
adults, according to research.
Lansing and Vuori referred to a column
in which Hiltzik opposed the measure because it would divert money
from more immediate state needs, including health and welfare
programs for children, education and the poor. (See here for thecolumn and here, here and here for related items.)
in which Hiltzik opposed the measure because it would divert money
from more immediate state needs, including health and welfare
programs for children, education and the poor. (See here for thecolumn and here, here and here for related items.)
In his most recent column, Hiltzik
said,
said,
"The...problem with Proposition 29
is its pigeonholing of the money for cancer research rather than for
immediate needs here in California that are absolutely dire. It’s
all well and good to say that cancer research benefits everyone, but
the real question is whether it should be the absolute top priority
for a state that can’t afford to keep its children fed or offer
them medical care in the here and now.
"Lansing and Vuori say the fact
that Prop. 29 'fails to provide funding for schools, roads or
affordable housing' is irrelevant, because it was 'was never intended
to solve these problems.'"In the context of the state’s
needs, this is a rather callous approach to take. Let’s spell out
why, so Lansing and Vuori won’t be so inclined to dismiss these
necessities of life so casually."
Hiltzik cited a list of state
government cuts that have meant the loss of health coverage for
400,000 California children, eliminated welfare benefits for 578,000
poor California families and would mean an end to state college
student aid for 72,000 young people from less affluent families.
government cuts that have meant the loss of health coverage for
400,000 California children, eliminated welfare benefits for 578,000
poor California families and would mean an end to state college
student aid for 72,000 young people from less affluent families.
Hiltzik continued,
"That’s just the beginning of
what might be cut because the state needs money—and won’t be able
to lay its hands on the hundreds of millions of dollars that Lansing,
Vuori, and their research colleagues are angling for. They don’t
want voters to be reminded that there are competing demands for the
tobacco money, and they do so by failing to mention that they exist,
and also by presenting the spending on cancer research as the voters’
only choice.
"It’s the only choice because
the promoters of Proposition 29 designed it that way. Advocates of
programs like this love to pass them in via voter initiatives because
they leave no room to measure them against alternative needs."
A final note: The New York Times
carried a piece yesterday on Proposition 29 that drew 481 comments.
The article said,
carried a piece yesterday on Proposition 29 that drew 481 comments.
The article said,
"Organizers argued that the tax would have
less chance of passing if voters thought it would go into the state
coffers, and said that their only goal here was cutting down on
smoking."
Also yesterday, Willie Brown, the former mayor
of San Francisco and a keen observer of California politics,
predicted voter approval of the measure along with an increase in
cigarette smuggling from adjacent states and the sale of discount
smokes at the 58 Indian casino sites in the state.
of San Francisco and a keen observer of California politics,
predicted voter approval of the measure along with an increase in
cigarette smuggling from adjacent states and the sale of discount
smokes at the 58 Indian casino sites in the state.
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss
Posted in Stem Cell Therapy
Comments Off on Two California Stem Cell Agency Directors Plump for Proposition 29
Stem cell therapy offers new treatment options for pets — and humans
Select a Publication: N E W S P A P E R S ---------------------------------------------- ---Alberta--- Airdrie - Airdrie Echo Banff - Banff Crag and Canyon Beaumont - Beaumont News Calgary - The Calgary Sun Camrose - Camrose Canadian Canmore - Canmore Leader Central Alberta - County Market Cochrane - Cochrane Times Cold Lake - Cold Lake Sun Crowsnest Pass - Crowsnest Pass Promoter Devon - Dispatch News Drayton - Drayton Valley Western Review Edmonton - Edmonton Examiner Edmonton - The Edmonton Sun Edson - Edson Leader Fairview - Fairview Post Fort McMurray - Fort McMurray Today Fort Saskatchewan - Fort Saskatchewan Record Grande Prairie - Daily Herald Tribune Hanna - Hanna Herald High River - High River Times Hinton - Hinton Parklander Lacombe - Lacombe Globe Leduc - Leduc Representative Lloydminster - Meridian Booster Mayerthorpe - Mayerthorpe Freelancer Nanton - Nanton News Peace Country - Peace Country Sun Peace River - Peace River Record Gazette Pincher Creek - Pincher Creek Echo Sherwood Park - Sherwood Park News Spruce Grove - Spruce Grove Examiner Stony Plain - Stony Plain Reporter Strathmore - Strathmore Standard Vermilion - Vermilion Standard Vulcan - Vulcan Advocate Wetaskiwin - Wetaskiwin Times Whitecourt - Whitecourt Star ---Manitoba--- Altona - Alton Red River Valley Echo Beausejour - Beausejour Review Carman - Carman Valley Leader Gimli - Interlake Spectator Lac Du Bonnet - Lac Du Bonnet Leader Morden - Morden Times Portage la Prairie - Portage Daily Graphic Selkirk - Selkirk Journal Stonewall - Stonewall Argus and Teulon Times Winkler - Winkler Times Winnipeg - The Winnipeg Sun ---Ontario--- Amherstburg - Amherstburg Echo Bancroft - Bancroft this Week Barrie - Barrie Examiner Barry's Bay - Barry's Bay this Week Belleville - Intelligencer Bradford - Bradford Times Brantford - Expositor Brockville - The Recorder & Times Chatham - Chatham Daily News Chatham - Chatham This Week Chatham - Today's Farmer Clinton - Clinton News-Record Cobourg - Northumberland Today Cochrane - Cochrane Times Post Collingwood - Enterprise Bulletin Cornwall - Standard Freeholder Delhi - Delhi News-Record Dresden - Leader Spirit Dunnville - Dunnville Chronicle Elliot Lake - Standard Espanola - Mid-North Monitor Fort Erie - Times Gananoque - Gananoque Reporter Goderich - Goderich Signal-Star Grand Bend - Lakeshore Advance Haliburton - Haliburton Echo Hanover - The Post Ingersoll - Ingersoll Times Innisfil - Innisfil Examiner Kapuskasing - Kapuskasing Northern Times Kenora - Kenora Daily Miner and News Kenora - Lake of the Woods Enterprise Kincardine - Kincardine News Kingston - Frontenac This Week Kingston - Kingston This Week Kingston - Kingston Whig Standard Kirkland Lake - Northern News Leamington - Leamington Post Lindsay - The Lindsay Post London - The London Free Press London - The Londoner Lucknow - Lucknow Sentinel Midland - Free Press Minden - Minden Times Mitchell - Mitchell Advocate Napanee - Napanee Guide Niagara-on-the-Lake - Niagara Advance Niagara Falls - Review Niagara Falls - Niagara Shopping News Niagara Falls - W. Niagara Community Newspapers North Bay - North Bay Nugget Northumberland - Northumberland Today Norwich - Norwich Gazette Orillia - Packet and Times Ottawa - The Ottawa Sun Owen Sound - Sun Times Oxford - Oxford Review Paris - Paris Star Online Pelham - Pelham News Pembroke - Daily Observer Peterborough - Peterborough Examiner Petrolia - Petrolia Topic Picton - County Weekly News Port Colborne - Inport News Port Hope - Northumberland Today Port Elgin - Shoreline Beacon Sarnia - Observer Sarnia - Sarnia This Week Sault Ste Marie - Sault Star Sault Ste Marie - Sault This Week Seaforth - Seaforth Huron Expositor Simcoe - Simcoe Reformer St. Catharines - St. Catharines Shopping News St. Catharines - Standard St. Thomas - St. Thomas Times-Journal Stirling - Community Press Stratford - The Beacon Herald Strathroy - Strathroy Age Dispatch Sudbury - Sudbury Star Thorold - Thorold News Tillsonburg - Tillsonburg News Timmins - Daily Press Timmins - Timmins Times Toronto - The Toronto Sun Trenton - Trentonian Wallaceburg - Wallaceburg Courier Press Welland - Tribune Welland - Welland News West Lorne - The Chronicle Wiarton - Wiarton Echo Woodstock - Sentinel Review ---Saskatchewan--- Meadow Lake - Meadow Lake Progress Melfort - Melfort Journal Nipawin - Nipawin Journal MAGAZINES & SPECIALTY PUBLICATIONS --------- Biz Magazine Business London Cottage Home and Property Showcase Food and Wine Show Hamilton Halton Weddings Hamilton Magazine InterVin International Wine Awards Kingston Life London Citylife Muskoka Magazine Muskoka Trails Niagara Food and Wine Expo Niagara Magazine Ontario Farmer Ontario Golf Sault Good Life Simcoe Life The Home Show Vines Magazine What's Up Muskoka
See original here:
Stem cell therapy offers new treatment options for pets -- and humans
Posted in Stem Cell Therapy
Comments Off on Stem cell therapy offers new treatment options for pets — and humans